| Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
| 08/04/2026 | REN Yong | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Fortune Fountain Investment Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Simcere Investments Group Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Simcere Pharmaceutical Holding Limited | 1201(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Simcere Holding Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Right Wealth Holdings Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | PENG SUQIN | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Excel Investments Group Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | REN WEIDONG | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | REN Jinsheng | 1213(L) | -44,952,853(L) | 1,731,390,215(L) | 66.70 | |
| 08/04/2026 | REN ZHEN | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | P&H Holdings Group Ltd. | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | Artking Global Limited | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | LI SHIMENG | 1213(L) | -44,952,853(L) | 1,730,875,815(L) | 66.68 | |
| 08/04/2026 | WANG Xi | 1213(L) | -44,952,853(L) | 1,731,390,215(L) | 66.70 | |
| 01/12/2025 | Wan Yushan | 1106(L) | +2,100,000(L) | 3,828,787(L) | 0.15 | |
| 01/12/2025 | REN Jinsheng | 1113(L) | +240,000(L) | 1,776,343,068(L) | 68.43 | |
| 01/12/2025 | WANG Xi | 1106(L) | +240,000(L) | 1,776,343,068(L) | 68.43 | |
| 10/09/2025 | WANG XI | 1113(L) | +121,000,000(L) | 1,776,103,068(L) | 68.42 | |
| 10/09/2025 | Excel Investments Group Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Simcere Pharmaceutical Holding Limited | 1111(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | LI SHIMENG | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | PENG SUQIN | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | REN ZHEN | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Tang Renhong | 1711(L) | 1,550,000(L) | 0.06 | ||
| 10/09/2025 | Wan Yushan | 1711(L) | 1,728,787(L) | 0.07 | ||
| 10/09/2025 | REN Yong | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Fortune Fountain Investment Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Simcere Investments Group Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Artking Global Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | Right Wealth Holdings Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | REN WEIDONG | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | P&H Holdings Group Ltd. | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 10/09/2025 | REN JINSHENG | 1113(L) | +121,000,000(L) | 1,776,103,068(L) | 68.42 | |
| 10/09/2025 | Simcere Holding Limited | 1113(L) | +121,000,000(L) | 1,775,828,668(L) | 68.41 | |
| 04/09/2025 | Artking Global Limited | 1213(L) | -121,000,000(L) | 1,654,828,668(L) | 66.87 | |
| 04/09/2025 | REN Yong | 1213(L) | -121,000,000(L) | 1,654,828,668(L) | 66.87 | |
| 04/09/2025 | Simcere Investments Group Limited | 1213(L) | -121,000,000(L) | 1,654,828,668(L) | 66.87 | |
| 04/09/2025 | PENG SUQIN | 1213(L) | -121,000,000(L) | 1,654,828,668(L) | 66.87 | |
| 04/09/2025 | LI SHIMENG | 1213(L) | -121,000,000(L) | 1,654,828,668(L) | 66.87 | |
| 1 2 3 | ||||||
| Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
| Real time quote last updated: 23/04/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |